Katabami Takuyuki, Asai Shiko, Matsuba Ren, Sone Masakatsu, Izawa Shoichiro, Ichijo Takamasa, Tsuiki Mika, Okamura Shintaro, Yoshimoto Takanobu, Otsuki Michio, Takeda Yoshiyu, Naruse Mitsuhide, Tanabe Akiyo
Endocr Connect. 2025 May 12;14(5). doi: 10.1530/EC-24-0684. Print 2025 May 1.
Adrenal Cushing syndrome (CS) has been rarely studied in recent years in Japan. This study aimed to investigate clinical characteristics and their changes over time in patients with adrenal CS. We analyzed 101 patients with adrenal CS caused by adenoma, dividing them into two groups based on diagnosis period: December 2011-November 2016 (later group, n = 50) and August 2005-November 2011 (earlier group, n = 51). Differences between the groups and comparisons with previous reports were assessed. Patients with subclinical CS were excluded. Adrenal incidentalomas were the most frequent reason for CS diagnosis (34%). Most patients exhibited few specific cushingoid features (2.5 ± 1.3), with moon faces and central obesity being the most common. Compared to earlier reports, specific cushingoid features were less frequent; nonetheless, no significant differences were observed between the earlier and later groups. All patients had midnight and post-dexamethasone suppression test serum cortisol levels exceeding 5 μg/dL. No significant differences were found between the groups regarding non-specific symptoms, endocrinological findings related to cortisol secretion, cardiometabolic commodities or infections, except for glucose intolerance and bone complications. The prevalence of metabolic disorders other than glucose intolerance and osteoporosis fluctuated over time. Sixteen patients developed cardiovascular diseases or severe infections. In conclusion, adrenal CS became less florid in the 2000s, showed no improvement in the following years, and remained associated with a high complication rate. Further research is needed to establish an early detection model for CS.
Our study found that one-sixth of patients with adrenal Cushing syndrome continued to develop severe complications in this century despite their specific cushingoid features being less pronounced than in the past. Notably, the findings provide clinical insights that may aid in earlier disease diagnosis.
近年来,日本对肾上腺皮质醇增多症(CS)的研究较少。本研究旨在调查肾上腺CS患者的临床特征及其随时间的变化。我们分析了101例由腺瘤引起的肾上腺CS患者,根据诊断时间将他们分为两组:2011年12月至2016年11月(后期组,n = 50)和2005年8月至2011年11月(早期组,n = 51)。评估了两组之间的差异以及与先前报告的比较。排除亚临床CS患者。肾上腺偶发瘤是CS诊断最常见的原因(34%)。大多数患者表现出较少的典型库欣样特征(2.5±1.3),其中满月脸和向心性肥胖最为常见。与早期报告相比,典型库欣样特征较少见;然而,早期组和后期组之间未观察到显著差异。所有患者午夜及地塞米松抑制试验后血清皮质醇水平均超过5μg/dL。除葡萄糖耐量异常和骨骼并发症外,两组在非特异性症状、与皮质醇分泌相关的内分泌学表现、心脏代谢指标或感染方面未发现显著差异。除葡萄糖耐量异常和骨质疏松症外,其他代谢紊乱的患病率随时间波动。16例患者发生了心血管疾病或严重感染。总之,肾上腺CS在21世纪变得不那么典型,在随后几年没有改善,并且仍然与高并发症发生率相关。需要进一步研究以建立CS的早期检测模型。
我们的研究发现,在本世纪,六分之一的肾上腺皮质醇增多症患者尽管其典型库欣样特征不如过去明显,但仍继续发生严重并发症。值得注意的是,这些发现提供了可能有助于早期疾病诊断的临床见解。